Skip to main content

Peer Review reports

From: The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

Original Submission
7 Jan 2010 Submitted Original manuscript
9 Feb 2010 Author responded Author comments - Sophie North
Resubmission - Version 2
9 Feb 2010 Submitted Manuscript version 2
22 Feb 2010 Author responded Author comments - Sophie North
Resubmission - Version 3
22 Feb 2010 Submitted Manuscript version 3
8 Mar 2010 Author responded Author comments - Sophie North
Resubmission - Version 4
8 Mar 2010 Submitted Manuscript version 4
Publishing
24 Mar 2010 Editorially accepted
24 Mar 2010 Article published 10.1186/1741-7015-8-19

You can find further information about peer review here.

Back to article page